These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30939952)

  • 1. Correlation and concordance measures between clinical, endoscopic and histological scores activity in Crohn's disease under treatment.
    Tajra JB; Calegaro JU; de Paula AP; Bachour D; Silveira D; Lozi M; Cavalcanti H
    Scand J Gastroenterol; 2019 Apr; 54(4):441-445. PubMed ID: 30939952
    [No Abstract]   [Full Text] [Related]  

  • 2. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
    Danese S; Sandborn WJ; Colombel JF; Vermeire S; Glover SC; Rimola J; Siegelman J; Jones S; Bornstein JD; Feagan BG
    Gastroenterology; 2019 Oct; 157(4):1007-1018.e7. PubMed ID: 31279871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between endoscopic and histological validated scoring indices in Crohn's disease.
    Gong W; Guo K; Zheng T; Fang M; Xie H; Li W; Hong Z; Ren H; Gu G; Wang G; Wu X; Wang Z; Ren J; Li J
    Dig Liver Dis; 2019 Jun; 51(6):812-817. PubMed ID: 30718202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
    Löwenberg M; Vermeire S; Mostafavi N; Hoentjen F; Franchimont D; Bossuyt P; Hindryckx P; Rispens T; de Vries A; van der Woude CJ; Berends S; Ambarus CA; Mathot R; Clasquin E; Baert F; D'Haens G
    Gastroenterology; 2019 Oct; 157(4):997-1006.e6. PubMed ID: 31175865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.
    Mantzaris GJ; Christidou A; Sfakianakis M; Roussos A; Koilakou S; Petraki K; Polyzou P
    Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease.
    Geboes K; Rutgeerts P; Opdenakker G; Olson A; Patel K; Wagner CL; Marano CW
    Curr Med Res Opin; 2005 Nov; 21(11):1741-54. PubMed ID: 16307694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Turunen U; Arkkila P; Sipponen T; Färkkilä M
    Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
    Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
    BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease.
    E Penna FGC; Rosa RM; da Cunha PFS; de Souza SCS; de Abreu Ferrari ML
    BMC Gastroenterol; 2020 Feb; 20(1):35. PubMed ID: 32054445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Sipponen T; Turunen U; Arkkila P; Färkkilä M
    Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease.
    Grover Z; Muir R; Lewindon P
    J Gastroenterol; 2014 Apr; 49(4):638-45. PubMed ID: 23636735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease.
    Lewis JD; Rutgeerts P; Feagan BG; D'haens G; Danese S; Colombel JF; Reinisch W; Rubin DT; Selinger C; Bewtra M; Barcomb L; Lacerda AP; Wallace K; Butler JW; Wu M; Zhou Q; Liao X; Sandborn WJ
    Inflamm Bowel Dis; 2020 Jan; 26(2):304-313. PubMed ID: 31644790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.
    Peyrin-Biroulet L; Reinisch W; Colombel JF; Mantzaris GJ; Kornbluth A; Diamond R; Rutgeerts P; Tang LK; Cornillie FJ; Sandborn WJ
    Gut; 2014 Jan; 63(1):88-95. PubMed ID: 23974954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple Enterographic Activity Score for Crohn's Disease: comparison with endoscopic, biochemical, and clinical findings.
    Eder P; Katulska K; Lykowska-Szuber L; Stawczyk-Eder K; Krela-Kaźmierczak I; Linke K
    Pol Arch Med Wewn; 2013; 123(7-8):378-85. PubMed ID: 23778300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic evaluation of Crohn's disease activity: comparison of the CDEIS and the SES-CD.
    Sipponen T; Nuutinen H; Turunen U; Färkkilä M
    Inflamm Bowel Dis; 2010 Dec; 16(12):2131-6. PubMed ID: 20848462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological Indices and Risk of Recurrence in Crohn's Disease: A Retrospective Study of a Cohort of Patients in Endoscopic Remission.
    Marion L; Amélie B; Zoubir D; Guillaume C; Elise MS; Hedia B; Margaux LS; Aude M; Camille BR
    Inflamm Bowel Dis; 2022 Sep; 28(9):1395-1404. PubMed ID: 35429159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.
    Daperno M; D'Haens G; Van Assche G; Baert F; Bulois P; Maunoury V; Sostegni R; Rocca R; Pera A; Gevers A; Mary JY; Colombel JF; Rutgeerts P
    Gastrointest Endosc; 2004 Oct; 60(4):505-12. PubMed ID: 15472670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.